77 related articles for article (PubMed ID: 37415201)
1. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
Ruan X; Huang D; Huang J; Tsu JH; Na R
J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
[TBL] [Abstract][Full Text] [Related]
3. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
[TBL] [Abstract][Full Text] [Related]
4. Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry.
Hughley RW; Matejcic M; Song Z; Sheng X; Wan P; Xia L; Hart SN; Hu C; Yadav S; Lubmawa A; Kiddu V; Asiimwe F; Amanya C; Mutema G; Job K; Ssebakumba MK; Ingles SA; Hamilton AS; Couch FJ; Watya S; Conti DV; Darst BF; Haiman CA
Cancer Res Commun; 2023 Dec; 3(12):2544-2550. PubMed ID: 38014910
[TBL] [Abstract][Full Text] [Related]
5. Validation of a prostate cancer polygenic risk score.
Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
[TBL] [Abstract][Full Text] [Related]
6. Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.
Zhang Y; Stopsack KH; Song M; Mucci LA; Liu B; Penney KL; Tabung FK; Giovannucci E; Plym A
Int J Cancer; 2024 Jul; 155(1):71-80. PubMed ID: 38429859
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer risk prediction using a polygenic risk score.
Sipeky C; Talala KM; Tammela TLJ; Taari K; Auvinen A; Schleutker J
Sci Rep; 2020 Oct; 10(1):17075. PubMed ID: 33051487
[TBL] [Abstract][Full Text] [Related]
8. A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease.
Bakshi A; Riaz M; Orchard SG; Carr PR; Joshi AD; Cao Y; Rebello R; Nguyen-Dumont T; Southey MC; Millar JL; Gately L; Gibbs P; Ford LG; Parnes HL; Chan AT; McNeil JJ; Lacaze P
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830967
[TBL] [Abstract][Full Text] [Related]
9. Polygenic Risk Prediction in Diverticulitis.
De Roo AC; Chen Y; Du X; Handelman S; Byrnes M; Regenbogen SE; Speliotes EK; Maguire LH
Ann Surg; 2023 Jun; 277(6):e1262-e1268. PubMed ID: 35876359
[TBL] [Abstract][Full Text] [Related]
10. Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set.
Vince RA; Sun H; Singhal U; Schumacher FR; Trapl E; Rose J; Cullen J; Zaorsky N; Shoag J; Hartman H; Jia AY; Spratt DE; Fritsche LG; Morgan TM
Eur Urol Oncol; 2024 May; ():. PubMed ID: 38734542
[TBL] [Abstract][Full Text] [Related]
11. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
Rumpf F; Plym A; Vaselkiv JB; Penney KL; Preston MA; Kibel AS; Mucci LA; Salari K
J Urol; 2024 Apr; ():101097JU0000000000003927. PubMed ID: 38598641
[TBL] [Abstract][Full Text] [Related]
12. Causal associations of histidine and 12 site-specific cancers: a bidirectional Mendelian randomization study.
Kong X; Yu J; Zhu Z; Wang C; Zhang R; Qi J; Wang Y; Wang X; Pan S; Liu L; Feng R
Mol Genet Genomics; 2023 Nov; 298(6):1331-1341. PubMed ID: 37498357
[TBL] [Abstract][Full Text] [Related]
13. Mendelian randomization and transcriptomic analysis reveal an inverse causal relationship between Alzheimer's disease and cancer.
Dong Z; Xu M; Sun X; Wang X
J Transl Med; 2023 Aug; 21(1):527. PubMed ID: 37542274
[TBL] [Abstract][Full Text] [Related]
14. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.
Yang X; Zhang Q; Li S; Devarajan R; Luo B; Tan Z; Wang Z; Giannareas N; Wenta T; Ma W; Li Y; Yang Y; Manninen A; Wu S; Wei GH
J Exp Clin Cancer Res; 2023 Aug; 42(1):198. PubMed ID: 37550764
[TBL] [Abstract][Full Text] [Related]
15. Genetically predicted thyroid function and risk of colorectal cancer: a bidirectional Mendelian randomization study.
Du Q; Zheng Z; Wang Y; Yang L; Zhou Z
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14015-14024. PubMed ID: 37543542
[TBL] [Abstract][Full Text] [Related]
16. Shared genetic architecture between irritable bowel syndrome and psychiatric disorders reveals molecular pathways of the gut-brain axis.
Tesfaye M; Jaholkowski P; Hindley GFL; Shadrin AA; Rahman Z; Bahrami S; Lin A; Holen B; Parker N; Cheng W; Rødevand L; Frei O; Djurovic S; Dale AM; Smeland OB; O'Connell KS; Andreassen OA
Genome Med; 2023 Aug; 15(1):60. PubMed ID: 37528461
[TBL] [Abstract][Full Text] [Related]
17. mGWAS-Explorer 2.0: Causal Analysis and Interpretation of Metabolite-Phenotype Associations.
Chang L; Zhou G; Xia J
Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512533
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variants Associated With Hidradenitis Suppurativa.
Sun Q; Broadaway KA; Edmiston SN; Fajgenbaum K; Miller-Fleming T; Westerkam LL; Melendez-Gonzalez M; Bui H; Blum FR; Levitt B; Lin L; Hao H; Harris KM; Liu Z; Thomas NE; Cox NJ; Li Y; Mohlke KL; Sayed CJ
JAMA Dermatol; 2023 Sep; 159(9):930-938. PubMed ID: 37494057
[TBL] [Abstract][Full Text] [Related]
19. Investigating the tissue specificity and prognostic impact of cis-regulatory cancer risk variants.
Subramanian A; Su S; Moding EJ; Binkley MS
Hum Genet; 2023 Sep; 142(9):1395-1405. PubMed ID: 37474751
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte.
Yang C; Liu Z; Fang Y; Cao X; Xu G; Wang Z; Hu Z; Wang S; Wu X
J Transl Med; 2023 Jul; 21(1):465. PubMed ID: 37438820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
